Pre-revenue StatusZero revenue across 2020–2025 shows the business model has not yet achieved commercial sales. Without revenue, there is no proven pricing or demand signal; continued dependence on R&D and external funding raises execution risk and makes long-term viability contingent on successful commercialization.
Persistent And Widening LossesWidening net losses in 2025 (~-4.9m vs ~-4.4m in 2024) alongside persistent negative operating cash flows mean the company is still far from profitability. Ongoing losses erode equity, increase funding needs, and constrain the firm’s ability to invest in scaling operations over the next several quarters.
Rising Leverage TrendLeverage has increased materially since 2022–2023 and debt-to-equity sits near 0.35. Rising leverage, combined with sustained losses, raises solvency and refinancing risk, increases fixed obligations, and reduces strategic flexibility during the multi-quarter path to commercialization.